SCHEMBL9532969

SCHEMBL9532969

O=c1c2c(c3cccnc3n1-c1ccccc1)CCO2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 7/20 0.52
PDE4B Q07343 6/20 0.52
PDE4C Q08493 6/20 0.52
PDE4D Q08499 6/20 0.52
FEN1 P39748 1/20 0.50
ALDH1A1 P00352 3/20 0.46
CYP2C19 P33261 2/20 0.46
TSHR P16473 1/20 0.46
LDHA P00338 1/20 0.44
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
LOXL3 P58215 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
KAT2B Q92831 1/20 0.38
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
REN P00797 2/20 0.36
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9630002 0.90 FEN1 (0.50) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL9629723 0.82 FEN1 (0.48) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL9630056 0.81 FEN1 (0.47) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL10377174 0.80 FEN1 (0.41) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL9352322 0.80 FEN1 (0.47) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL9629050 0.79 HPGD (0.47) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL9629850 0.79 HPGD (0.47) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL9629742 0.79 CYP2C19 (0.47) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL9535305 0.79 FEN1 (0.55) PDE4APDE4BPDE4CPDE4DFEN1
SCHEMBL9532938 0.79 FEN1 (0.55) PDE4APDE4BPDE4CPDE4DFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0241291-B1 ARYL-SUBSTITUTED NAPHTHYRIDINE AND PYRIDOPYRAZINE DERIVATIVES SCHERING CORPORATION (US) 1993-06-02 EP claimed
EP-0241291-A2 Aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1987-10-14 EP claimed
EP-0241291-B1 ARYL-SUBSTITUTED NAPHTHYRIDINE AND PYRIDOPYRAZINE DERIVATIVES SCHERING CORPORATION (US) 1993-06-02 EP disclosed
US-5045542-A Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1991-09-03 US disclosed
US-5011860-A Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases SCHERING CORPORATION (US) 1991-04-30 US disclosed
US-4882332-A Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1989-11-21 US disclosed
US-4866061-A TREATMENT OF ALLERGIC REACTIONS, ULCERS, INFLAMMATION SCHERING CORPORATION (US) 1989-09-12 US disclosed
US-4760073-A Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents SCHERING CORPORATION (US) 1988-07-26 US disclosed
EP-0241291-A2 Aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1987-10-14 EP disclosed